Lipidized glioblastoma: Pathological and molecular characteristics

Neuropathology, 06/15/2012

To the best of the knowledge, this is the first time MGMT promoter status and IDH mutation assessment have been reported in a case of lipidized glioblastoma multiforme (GBM).

Print Article Summary Cat 2 CME Report